ID

38009

Description

Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01446185

Link

https://clinicaltrials.gov/show/NCT01446185

Keywords

Versions (1)
  1. 9/8/19 9/8/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 8, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT01446185

English

Eligibility Breast Cancer NCT01446185

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients > 18 years old.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
2. pre- or post- menopausal women with breast adenocarcinoma, confirmed by a pathologist and who underwent surgery, with a maximum of 4 weeks between surgery and the 2nd therapeutic decision with oncotype dx.
Description

Premenopausal state | Postmenopausal state | Breast adenocarcinoma | Operative Surgical Procedure

Data type

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C0232970
UMLS CUI [3]
C0858252
UMLS CUI [4]
C0543467
3. hr positive (at least er+) breast cancer patients (defined by a threshold of 10% of the cells ihc + without n- or pn1(mi), her2 - (ihc0, 1, 2+ or fish -)
Description

Breast Carcinoma Hormone Receptor Positive | Oestrogen receptor positive breast cancer | Cells Positive Percentage Immunohistochemistry | TNM Breast tumor staging | Breast Carcinoma HER2 Negative | Immunohistochemistry | Fluorescent in Situ Hybridization Negative

Data type

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0019929
UMLS CUI [1,3]
C1514241
UMLS CUI [2]
C2938924
UMLS CUI [3,1]
C0007634
UMLS CUI [3,2]
C1514241
UMLS CUI [3,3]
C0439165
UMLS CUI [3,4]
C0021044
UMLS CUI [4]
C0474926
UMLS CUI [5,1]
C0678222
UMLS CUI [5,2]
C2348908
UMLS CUI [6]
C0021044
UMLS CUI [7,1]
C0162789
UMLS CUI [7,2]
C1513916
4. patients must be eligible to receive adjuvant chemotherapy as defined by a good karnofsky index, no hematological, cardiological or hepatic contraindications nor any impeding comorbidity.
Description

Patients Eligible Adjuvant Chemotherapy | Karnofsky Performance Status Good | Medical contraindication Hematologic Absent | Medical contraindication cardiac Absent | Medical contraindication Hepatic Absent | Comorbidity Limiting Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548635
UMLS CUI [1,3]
C0085533
UMLS CUI [2,1]
C0206065
UMLS CUI [2,2]
C0205170
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0205488
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C1301624
UMLS CUI [4,2]
C0018787
UMLS CUI [4,3]
C0332197
UMLS CUI [5,1]
C1301624
UMLS CUI [5,2]
C0205054
UMLS CUI [5,3]
C0332197
UMLS CUI [6,1]
C0009488
UMLS CUI [6,2]
C0439801
UMLS CUI [6,3]
C0332197
5. patients must have given a written informed consent.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. t3 or t4, hr-, n+ (except pn1 (mi) (sn), her2+ (ihc 3+ or fish+) patients.
Description

TNM Breast tumor staging | Breast Carcinoma Hormone Receptor Negative | HER2-positive carcinoma of breast | Immunohistochemistry | FISH Positive

Data type

boolean

Alias
UMLS CUI [1]
C0474926
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C0019929
UMLS CUI [2,3]
C1513916
UMLS CUI [3]
C1960398
UMLS CUI [4]
C0021044
UMLS CUI [5,1]
C0162789
UMLS CUI [5,2]
C1514241
2. metastatic patients.
Description

Patients metastatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1522484
3. patients who cannot give an informed consent.
Description

Informed Consent Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
4. patients who cannot receive chemotherapy.
Description

Chemotherapy Receive Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
5. patient who participated in another clinical trial and is still in the exclusion period of any other trial.
Description

Study Subject Participation Status | Exclusion Period Clinical Trial

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C2828389
UMLS CUI [2,2]
C1948053
UMLS CUI [2,3]
C0008976
6. mentally disabled patient who has no legal responsibility for herself.
Description

Mental handicap | Legal responsibility Self Lacking

Data type

boolean

Alias
UMLS CUI [1]
C1306341
UMLS CUI [2,1]
C0162399
UMLS CUI [2,2]
C0036588
UMLS CUI [2,3]
C0332268
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT01446185

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. patients > 18 years old.
boolean
C0001779 (UMLS CUI [1])
Premenopausal state | Postmenopausal state | Breast adenocarcinoma | Operative Surgical Procedure
Item
2. pre- or post- menopausal women with breast adenocarcinoma, confirmed by a pathologist and who underwent surgery, with a maximum of 4 weeks between surgery and the 2nd therapeutic decision with oncotype dx.
boolean
C0232969 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0858252 (UMLS CUI [3])
C0543467 (UMLS CUI [4])
Breast Carcinoma Hormone Receptor Positive | Oestrogen receptor positive breast cancer | Cells Positive Percentage Immunohistochemistry | TNM Breast tumor staging | Breast Carcinoma HER2 Negative | Immunohistochemistry | Fluorescent in Situ Hybridization Negative
Item
3. hr positive (at least er+) breast cancer patients (defined by a threshold of 10% of the cells ihc + without n- or pn1(mi), her2 - (ihc0, 1, 2+ or fish -)
boolean
C0678222 (UMLS CUI [1,1])
C0019929 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
C2938924 (UMLS CUI [2])
C0007634 (UMLS CUI [3,1])
C1514241 (UMLS CUI [3,2])
C0439165 (UMLS CUI [3,3])
C0021044 (UMLS CUI [3,4])
C0474926 (UMLS CUI [4])
C0678222 (UMLS CUI [5,1])
C2348908 (UMLS CUI [5,2])
C0021044 (UMLS CUI [6])
C0162789 (UMLS CUI [7,1])
C1513916 (UMLS CUI [7,2])
Patients Eligible Adjuvant Chemotherapy | Karnofsky Performance Status Good | Medical contraindication Hematologic Absent | Medical contraindication cardiac Absent | Medical contraindication Hepatic Absent | Comorbidity Limiting Absent
Item
4. patients must be eligible to receive adjuvant chemotherapy as defined by a good karnofsky index, no hematological, cardiological or hepatic contraindications nor any impeding comorbidity.
boolean
C0030705 (UMLS CUI [1,1])
C1548635 (UMLS CUI [1,2])
C0085533 (UMLS CUI [1,3])
C0206065 (UMLS CUI [2,1])
C0205170 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0205488 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C1301624 (UMLS CUI [4,1])
C0018787 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
C1301624 (UMLS CUI [5,1])
C0205054 (UMLS CUI [5,2])
C0332197 (UMLS CUI [5,3])
C0009488 (UMLS CUI [6,1])
C0439801 (UMLS CUI [6,2])
C0332197 (UMLS CUI [6,3])
Informed Consent
Item
5. patients must have given a written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
TNM Breast tumor staging | Breast Carcinoma Hormone Receptor Negative | HER2-positive carcinoma of breast | Immunohistochemistry | FISH Positive
Item
1. t3 or t4, hr-, n+ (except pn1 (mi) (sn), her2+ (ihc 3+ or fish+) patients.
boolean
C0474926 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0019929 (UMLS CUI [2,2])
C1513916 (UMLS CUI [2,3])
C1960398 (UMLS CUI [3])
C0021044 (UMLS CUI [4])
C0162789 (UMLS CUI [5,1])
C1514241 (UMLS CUI [5,2])
Patients metastatic
Item
2. metastatic patients.
boolean
C0030705 (UMLS CUI [1,1])
C1522484 (UMLS CUI [1,2])
Informed Consent Unable
Item
3. patients who cannot give an informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Chemotherapy Receive Unable
Item
4. patients who cannot receive chemotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Study Subject Participation Status | Exclusion Period Clinical Trial
Item
5. patient who participated in another clinical trial and is still in the exclusion period of any other trial.
boolean
C2348568 (UMLS CUI [1])
C2828389 (UMLS CUI [2,1])
C1948053 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Mental handicap | Legal responsibility Self Lacking
Item
6. mentally disabled patient who has no legal responsibility for herself.
boolean
C1306341 (UMLS CUI [1])
C0162399 (UMLS CUI [2,1])
C0036588 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial